BPC-157 Canada | Research Guide
Share
Canada Research Guide Research Use Only Updated June 2026
BPC-157 Canada Research Guide
BPC-157 is the most widely requested recovery research peptide in Canada. This guide covers what BPC-157 is, its published research profile across cytoprotective and tissue-repair models, why purity documentation matters, how it compares to related recovery compounds, and what Canadian researchers should evaluate when selecting a supplier.
Direct Answer: BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid pentadecapeptide derived from a protective protein found in human gastric juice. It has been studied in over 100 published non-clinical investigations for cytoprotective, tissue-repair, and anti-inflammatory signaling properties. CAS Number: 137525-51-0. For Canadian researchers, key sourcing factors include ≥99% purity with third-party HPLC and mass spectrometry verification, batch-specific COA documentation, and reliable domestic shipping.
Review BPC-157 Product Details and Documentation
View BPC-157 10mg View BPC-157 5mg Lab Results / COAsJump to a section
What Is BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids. It is a partial sequence of a body protection compound (BPC) that was first isolated from human gastric juice. Unlike many synthetic peptides, BPC-157 is notable for its stability in gastric conditions, which is unusual for peptides of its size and has contributed to sustained research interest.
The compound has been studied in non-clinical models for over two decades, with published investigations spanning gastrointestinal cytoprotection, musculoskeletal tissue repair, vascular function, and neurological signaling pathways. It remains one of the most requested research peptides in Canada.
| Property | Detail |
|---|---|
| Compound Name | BPC-157 (Body Protection Compound-157) |
| Molecular Class | Synthetic pentadecapeptide |
| Amino Acid Length | 15 amino acids |
| Origin | Derived from gastric juice body protection compound |
| CAS Number | 137525-51-0 |
| Research Format | Lyophilized powder |
| Key Feature | Gastric stability unusual for peptides of this class |
| Use Context | Laboratory and non-clinical research only |
BPC-157 Research Profile and Mechanisms
BPC-157 research spans multiple biological systems. The compound has been investigated for activity in the following non-clinical research areas:
| Research Area | Investigated Mechanism | Key Pathways |
|---|---|---|
| Gastrointestinal cytoprotection | Gastric mucosal integrity, ulcer models | NO system, prostaglandin modulation |
| Musculoskeletal tissue | Tendon, ligament, and muscle repair models | VEGF, EGF, FAK-paxillin signaling |
| Vascular function | Angiogenesis, blood vessel formation | VEGF pathway, nitric oxide system |
| Neuroprotective research | Dopaminergic and serotonergic models | CNS signaling pathways |
| Anti-inflammatory models | Inflammatory response modulation | Cytokine signaling, NO pathway |
The breadth of published research is notable — BPC-157 appears in over 100 published studies, which is exceptionally high for a synthetic research peptide. This research density makes it a compound of significant interest for investigators working across multiple biological systems.
Key Published Studies
The following peer-reviewed publications represent landmark research in the BPC-157 literature. Each is indexed in PubMed with a unique PMID for verification.
| Study | Focus | Key Finding |
|---|---|---|
| Sikiric et al., 1999 (PMID: 10574216) | Cytoprotective profile | Established BPC-157's gastric protection and tissue-repair signaling across multiple organ systems |
| Brcic et al., 2009 (PMID: 20065503) | Vascular pathways | Demonstrated involvement in angiogenesis and nitric oxide pathway modulation |
| Seiwerth et al., 2018 (PMID: 29589535) | Comprehensive review | Summarized the full body of BPC-157 literature across cytoprotective, tissue-repair, and neuroprotective contexts |
| Chang et al., 2011 (PMID: 21238868) | Tendon healing | Evaluated tendon-to-bone healing acceleration in rodent models |
| Vukojevic et al., 2020 (PMID: 32098014) | Neuroprotective effects | Investigated neuroprotective signaling and dopaminergic pathway interactions |
Note: All studies are non-clinical research. BPC-157 is not approved for therapeutic use. ThePeptide.ca materials are intended strictly for laboratory research.
Why Purity Matters for BPC-157 Research
Because BPC-157 is widely available from multiple suppliers, quality variation is a significant concern. Researchers should evaluate suppliers based on documentation transparency, not just product availability.
| Quality Signal | Why It Matters |
|---|---|
| ≥99% purity (HPLC verified) | Reduces variables and improves consistency across research protocols |
| Mass spectrometry confirmation | Confirms molecular identity matches target compound |
| Batch-specific COA | Links documentation to the specific lot you received |
| Third-party testing | Independent verification removes self-reporting bias |
| Published lab results | Transparent quality evidence accessible before purchase |
ThePeptide.ca provides batch-specific third-party testing through Testides (Toronto), with HPLC and mass spectrometry verification on every batch. View current lab results →
Storage and Handling for BPC-157
BPC-157 is notable for its relative gastric stability compared to other peptides of similar size. However, proper storage remains essential for research consistency.
| Condition | Recommendation |
|---|---|
| Lyophilized (unopened) | Store at -20°C for long-term; 2-8°C for short-term |
| Reconstituted | Refrigerate at 2-8°C, use within 21 days |
| Reconstitution solvent | Bacteriostatic water (0.9% benzyl alcohol) |
| Light exposure | Protect from direct light |
| Freeze-thaw | Minimize cycles — aliquot for multiple uses |
For step-by-step reconstitution instructions, see our How to Reconstitute Peptides guide. Purchase Bacteriostatic Water and Insulin Syringes as essential reconstitution supplies.
Why Canadian Researchers Choose Domestic BPC-157 Suppliers
- No customs delays or seizure risk — Domestic shipping avoids border inspections entirely
- Faster delivery — ThePeptide.ca ships from British Columbia with 1–3 day tracked delivery Canada-wide
- Temperature control — Shorter transit reduces temperature fluctuation exposure
- Canadian dollar pricing — No exchange rate markup or hidden conversion fees
- Local support — Canadian customer service at info@thepeptide.ca
BPC-157 vs Related Recovery Compounds
| Feature | BPC-157 | TB-500 (Thymosin Beta-4) | Healing Blend |
|---|---|---|---|
| Peptide class | Pentadecapeptide (15 aa) | 43-amino-acid peptide | BPC-157 + TB-500 combined |
| Primary mechanism | NO pathway, VEGF/EGF signaling | Actin sequestration, cell migration | Dual-pathway activation |
| Research focus | Cytoprotection, GI, musculoskeletal | Wound healing, cardiac tissue | Combined recovery models |
| Gastric stability | Unusually stable | Standard peptide stability | Blend-dependent |
| Published studies | 100+ non-clinical | Extensive thymosin literature | Emerging combination data |
Researchers studying combined recovery pathways can explore our Healing Blend (BPC-157 + TB-500) →
Frequently Asked Questions
What is BPC-157 used for in research?
Is BPC-157 legal to purchase in Canada?
What makes BPC-157 different from other recovery peptides?
What purity should I look for when buying BPC-157 in Canada?
How should BPC-157 be stored?
Does ThePeptide.ca ship BPC-157 across Canada?
Related Research Resources
References
- Sikiric P, et al. The pharmacological properties of the novel peptide BPC 157 (PL-10). Journal of Physiology-Paris. 1999;93(1-6):65-77. PubMed: 10574216
- Brcic L, et al. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. Journal of Physiology and Pharmacology. 2009;60 Suppl 7:191-196. PubMed: 20065503
- Seiwerth S, et al. BPC 157 and Blood Vessels. Current Pharmaceutical Design. 2018;24(18):1955-1969. PubMed: 29589535
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011;110(3):774-780. PubMed: 21238868
- Vukojevic J, et al. Rat inferior caval vein (ICV) ligature and the BPC 157 effects on the NSAID-induced lesion aggravation. Current Pharmaceutical Design. 2020;26(25):2956-2965. PubMed: 32098014
For laboratory and research use only. The information on this page is provided for educational and research-context purposes. ThePeptide.ca materials are not represented as approved for human use, veterinary use, or therapeutic application.
Shop This Compound
Every batch is third-party lab tested with a published COA, shipped same-day from BC: BPC-157 10mg · BPC-157 5mg. Browse the full collection →